Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis - European Medical Journal

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now